✦ LIBER ✦

A biochemotherapy regimen had `impressive antitumour effects' in patients with metastatic melanoma,

Book ID: 120868958
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2000
Weight: 151 KB
Volume: 1248
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200012480-00037

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biochemotherapy of metastatic melanoma i

Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases

✍ Martin Majer; Randy L. Jensen; Dennis C. Shrieve; Gordon A. Watson; Michael Wang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract ## BACKGROUND. Brain metastases are an alarming complication of advanced melanoma, frequently contributing to patient demise. The authors performed a retrospective analysis to determine whether the treatment of metastatic melanoma with biochemotherapy would result in similar outcomes i

Analysis of therapeutic and immunologic

Analysis of therapeutic and immunologic effects of R24 anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma

✍ John M. Kirkwood; Ruth A. Mascari; Howard D. Edington; Michael S. Rabkin; Roger 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB

## BACKGROUND. Antitumor effects of antibodies against ganglioside antigens of melanoma have been reported, but neither optimal doses nor mechanisms have been established. ## METHODS. This Phase IB trial of the murine immunoglobulin IgG 3 monoclonal antibody R 24 against disialoganglioside GD3

A randomized study comparing epirubicin

A randomized study comparing epirubicin in a 4-weekly versus a weekly intravenous regimen in patients with metastatic, hormone resistant, prostatic carcinoma: effects on health related quality of life

✍ G. van Andel; P. Fernandez de Moral; C. T. M. Caris; P. Carpentier; J. Wils; M. 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 195 KB

PCN83 Cost Effectiveness Analysis in the

PCN83 Cost Effectiveness Analysis in the Veneto Region of Cabazitaxel Versus Mitoxantrone in Patients with Metastatic Hormone Refractory Prostate Cancer, Previously Treated With a Docetaxel Containing Regimen

✍ P.R. Maran; A. Aiello; M.R. Magrì; C. Alberti; E. Visentin; F. Venturini; G. Scr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

OP4. Cost-effectiveness of Irinotecan (C

OP4. Cost-effectiveness of Irinotecan (CPT-11) and best estimated chemotherapy regimen in patients with metastatic colorectal cancer after failure of 5fluorouracil (5FU) containing regimen: Results based on a phase III trial

✍ G Blijham; C Schmitt; P Aussage; B Henry-Launois; B Jolain; P Hérait 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Phase I/II open-label study of the biolo

Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma

✍ Antoni Ribas; John M Kirkwood; Michael B Atkins; Theresa L Whiteside; William Go 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 784 KB